Acute ischemic stroke is infrequent in patients with COVID-19 and usually occurs in the presence of other cardiovascular risk factors.
The primary goal of this study was to assess whether autologous modiﬁed mesenchymal stem cells improve recovery in patients with chronic major stroke.
Study authors assessed the risk of stroke and systemic embolism in patients with atrial fibrillation and heart failure according to HF types.
At the 2021 International Stroke Conference, researchers presented their findings on stroke among men with COVID-19 and high comorbidity burden.
Telmisartan, an angiotensin II receptor blocker, is indicated for the treatment of hypertension.
Black residents are underrepresented as participants in clinical trials to support the approval of cardiovascular drugs in the United States.
At the 2021 International Stroke Conference, researchers presented their findings on the differences in poststroke depression between elderly men and women.
Researchers investigated the clinical and safety outcomes of mechanical thrombectomy for isolated posterior circulation DMVO stroke and compared them with standard medical treatment.
Study researchers presented their findings regarding race differences in 10-year mortality following ischemic stroke during the 2021 International Stroke Conference.
For patients who are new to therapy for valvular atrial fibrillation (AF), direct oral anticoagulants (DOACs) as a class are effective and safe compared with warfarin, with some variability among individual DOACs